Data / Research funding / Valley Fever
Valley Fever: 46 NIH awards ($74.5M) to 29 organizations
46 NIH awards ($74.5M) in the NIH spending category Valley Fever, to 29 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
46 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| WaNPRC Macaca nemestrina SPF Breeding Colony | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $11,361,503 | September 30, 2002 | June 30, 2028 | FULLER, DEBORAH H. | reporter.nih.gov |
| Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,218,182 | August 24, 2022 | July 31, 2027 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| Molecules and Pathways at the Coccidioides Host-Pathogen Interface | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,052,234 | January 1, 2022 | December 31, 2026 | SIL, ANITA | reporter.nih.gov |
| Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $4,889,710 | June 7, 2024 | June 1, 2026 | BRUYETTE, DAVID | reporter.nih.gov |
| Large Scale T Cell Epitope Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,323,930 | September 29, 2019 | September 29, 2025 | GAGE, KASIA | reporter.nih.gov |
| Integrating epidemiologic and environmental approaches to understand and predict Coccidioides exposure and coccidioidomycosis emergence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,707,638 | December 9, 2019 | November 30, 2025 | REMAIS, JUSTIN V | reporter.nih.gov |
| Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,198,798 | September 30, 2025 | September 29, 2026 | EVANS, JAY | reporter.nih.gov |
| Airway Innate Immune Responses to Coccidioides Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,075,549 | July 28, 2025 | June 30, 2029 | CHEN, YIN | reporter.nih.gov |
| Development of Coccidioides Cytokine Release Assay | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,971,862 | August 1, 2023 | July 31, 2027 | HOLBROOK, ERIC | reporter.nih.gov |
| Evolutionary multispecies transcriptomics to reveal genes that govern fungal spore germination and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,261,105 | May 16, 2019 | April 30, 2025 | TOWNSEND, JEFFREY PETER | reporter.nih.gov |
| Task A89: Candidate Testing in Murine Models of Fungal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,980,726 | May 1, 2024 | April 30, 2025 | PATTERSON, THOMAS | reporter.nih.gov |
| Expanding Swabseq sequencing technology to enable readiness for emerging pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,723,908 | July 11, 2023 | June 30, 2028 | ESKIN, ELEAZAR | reporter.nih.gov |
| Mechanisms of anti-fungal Vaccine immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,722,771 | May 1, 1997 | May 31, 2025 | KLEIN, BRUCE STEVEN | reporter.nih.gov |
| Mechanisms of vaccine immunity against coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,630,014 | February 1, 2023 | January 31, 2028 | KLEIN, BRUCE STEVEN | reporter.nih.gov |
| Serological Biomarkers for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,518,970 | June 7, 2021 | May 31, 2026 | MAGEE, D MITCHELL | reporter.nih.gov |
| Novel antifungal agents against coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,496,572 | July 17, 2024 | May 31, 2029 | WALCZAK, MACIEJ | reporter.nih.gov |
| Rapid immunoassay for diagnosis of coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $1,469,691 | September 30, 2022 | September 29, 2025 | BURNHAM MARUSCICH, AMANDA | reporter.nih.gov |
| Fungal Antigen Resources for Development of Vaccines and Diagnostics | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,193,457 | July 21, 2025 | June 30, 2030 | LEVITZ, STUART MICHAEL | reporter.nih.gov |
| DMS/NIGMS 2: Spatial, Multi-Host Petri Net Models for Zoonotic Disease Forecasting | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $854,662 | September 1, 2023 | August 31, 2027 | STERNER, BECKETT | reporter.nih.gov |
| Development of a multivalent vaccine against Coccidioides infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $756,656 | May 8, 2018 | April 30, 2025 | HUNG, CHIUNG-YU | reporter.nih.gov |
| Development of Coccidioides Cytokine Release Assay | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $596,247 | March 1, 2021 | February 28, 2023 | WHEAT, LAWRENCE JOSEPH | reporter.nih.gov |
| Proteome-wide Discovery of Diagnostic Targets for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $523,993 | December 1, 2023 | October 31, 2025 | MEAD, HEATHER LYNN | reporter.nih.gov |
| Breath Volatile Metabolites for the Diagnosis of Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $492,842 | December 15, 2020 | November 30, 2023 | KOO, SOPHIA | reporter.nih.gov |
| Mechanisms of Vaccine Immunity against Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $489,468 | May 16, 2022 | January 31, 2023 | KLEIN, BRUCE STEVEN | reporter.nih.gov |
| Host Responses to Coccidioides by Human Airway Epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $462,000 | May 2, 2022 | April 30, 2025 | VYAS, JATIN M | reporter.nih.gov |
| Dust storms and emergency department visits in four southwestern US states | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $452,963 | March 16, 2021 | February 29, 2024 | CHANG, HOWARD H | reporter.nih.gov |
| Rational design of a novel rapid diagnostic tool for coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $451,582 | January 23, 2023 | December 31, 2024 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| Investigation of key proteases in the parasitic phase of Coccidioides | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $444,125 | June 2, 2022 | May 31, 2024 | SIL, ANITA | reporter.nih.gov |
| Immune regulation to Coccidioides infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $442,470 | September 13, 2023 | August 31, 2025 | HOYER, KATRINA K | reporter.nih.gov |
| Regulation of infectious spore formation in the fungal pathogen Coccidioides posadasii | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $438,038 | July 15, 2025 | June 30, 2027 | BREM, RACHEL BETH | reporter.nih.gov |
| T-cell Dysfunction as the basis of Disseminated Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,986 | February 2, 2021 | January 31, 2024 | BUTTE, MANISH J | reporter.nih.gov |
| Optimization of antigen preparations from Coccidioides for diagnostic testing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $414,816 | December 1, 2020 | November 30, 2023 | GRYS, THOMAS E | reporter.nih.gov |
| Modelled estimation of population immunity for coccidioidomycosis and the role of immunologically naïve populations in the shifting epidemiology of coccidioidomycosis in California | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $356,356 | August 3, 2023 | July 31, 2028 | HEAD, JENNIFER | reporter.nih.gov |
| Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $302,500 | December 6, 2022 | November 30, 2024 | SHAFER, DAVID A | reporter.nih.gov |
| Understanding the natural Coccidioides bioaerosol in time and space and its relationship to disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $287,269 | March 16, 2020 | February 28, 2023 | ENGELTHALER, DAVID M | reporter.nih.gov |
| Exploratory study of pesticide use and coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $247,621 | May 15, 2025 | April 30, 2027 | PARSONNET, JULIE | reporter.nih.gov |
| A Point-of-Care Test for Rapid Diagnosis of Valley Fever | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $243,118 | July 24, 2023 | June 30, 2025 | GRILL, FRANCISCA | reporter.nih.gov |
| Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $220,750 | January 1, 2020 | December 31, 2022 | HUNG, CHIUNG-YU | reporter.nih.gov |
| Systems-level genetic patterns underlying disseminated coccidioidomycosis in humans | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $204,162 | March 6, 2020 | September 30, 2022 | LUSSIER, YVES A | reporter.nih.gov |
| Splice modulatory therapy for valley fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,448 | June 1, 2020 | May 31, 2023 | BURKART, MICHAEL D. | reporter.nih.gov |
| Regulatory T cell function in predicting Valley fever outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $192,460 | March 9, 2020 | August 31, 2023 | HOYER, KATRINA K | reporter.nih.gov |
| Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $97,851 | August 31, 2021 | February 28, 2024 | TEJEDA-GARIBAY, SUSANA | reporter.nih.gov |
| Repurposing Drugs to Discover Novel Antifungals for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $37,513 | September 1, 2024 | August 31, 2025 | SAEGER, SARAH BETH | reporter.nih.gov |
| Elucidating the role of rodent hosts on the transmission dynamics of coccidioidomycosis in California | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $37,077 | August 1, 2020 | May 16, 2022 | HEAD, JENNIFER | reporter.nih.gov |
| Support for the 68th annual meeting of Coccidioidomycosis study group | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $6,000 | March 18, 2024 | February 28, 2025 | HUNG, CHIUNG-YU | reporter.nih.gov |
| 69th Annual Coccidioidomycosis Study Group Scientific Conference | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,000 | January 27, 2025 | December 31, 2025 | LAKE, DOUGLAS F. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Washington | Seattle, WA | 1 | $11.4 million | 0 | $0 |
| Northern Arizona University | Flagstaff, AZ | 2 | $9.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $7.5 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 2 | $5.5 million | 0 | $0 |
| Anivive Lifesciences, INC | Long Beach, CA | 1 | $4.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 3 | $4.2 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 3 | $3.8 million | 0 | $0 |
| Miravista Diagnostics, LLC | Indianapolis, IN | 2 | $3.6 million | 0 | $0 |
| University of Montana | Missoula, MT | 1 | $3.2 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 1 | $3.1 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 3 | $2.4 million | 0 | $0 |
| Yale University | New Haven, CT | 1 | $2.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 2 | $2.1 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 1 | $2 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 1 | $1.5 million | 0 | $0 |
| Dxdiscovery, Inc. | Reno, NV | 1 | $1.5 million | 0 | $0 |
| University of Texas at San Antonio | San Antonio, TX | 4 | $1 million | 0 | $0 |
| Translational Genomics Research Inst | Phoenix, AZ | 2 | $811,262 | 0 | $0 |
| University of California - Merced | Merced, CA | 3 | $732,781 | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 1 | $492,842 | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 1 | $462,000 | 0 | $0 |
| Emory University | Atlanta, GA | 1 | $452,963 | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 1 | $414,816 | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 1 | $356,356 | 0 | $0 |
| Genetag Technology, Inc. | Atlanta, GA | 1 | $302,500 | 0 | $0 |
| Stanford University | Stanford, CA | 1 | $247,621 | 0 | $0 |
| Cactus Bio, LLC | Scottsdale, AZ | 1 | $243,118 | 0 | $0 |
| University of Utah | Salt Lake City, UT | 1 | $204,162 | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 1 | $197,448 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 16 | $15,805,922 | 0 | $0 |
| 2024 | 20 | $20,112,997 | 0 | $0 |
| 2023 | 21 | $15,685,096 | 0 | $0 |
| 2022 | 20 | $13,577,052 | 0 | $0 |
| 2021 | 20 | $9,292,526 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 37 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 37 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 37 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.